HighTower Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

HighTower Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,870	Closed	-$562K	–	2345
2017 Q1	$562K	Buy	4,870 +920	+23%	+$102K	0.01%	1271
2016 Q4	$408K	Buy	3,950 +700	+22%	+$73.3K	﹤0.01%	1345
2016 Q3	$355K	Buy	+3,250	New	+$430K	﹤0.01%	1388

Other funds holding TARO

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HighTower Advisors's TARO Position: Q2 2017 in Review

HighTower Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2017, closing a stake of 4,870 shares — an estimated $562K sold.

HighTower Advisors first reported a position in TARO in Q3 2016 and held it in 3 quarters. The position peaked at $562K in Q1 2017. 140 funds tracked by Wall St. Rank hold TARO as of Q2 2017.

HighTower Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2017 after selling out during the quarter.
HighTower Advisors sold 4,870 Taro Pharmaceutical Industries Ltd. shares in Q2 2017, an estimated $562K.
HighTower Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2016 and held it in 3 quarters.
HighTower Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $562K in Q1 2017.
140 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2017.

Based on HighTower Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.